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Sheeppox virus and goatpox virus cause systemic disease in sheep and goats that is often associated with high morbidity and high mortality. To
increase understanding of the pathogenesis of these diseases, we undertook quantitative time-course studies in sheep and goats following
intradermal inoculation of Nigerian sheeppox virus or Indian goatpox virus in their respective homologous hosts. Viremia, determined by virus
isolation and real-time PCR, cleared within 2 to 3 weeks post inoculation. Peak shedding of viral DNA and infectious virus in nasal, conjunctival
and oral secretions occurred between 10 and 14 days post inoculation, and persisted at low levels for up to an additional 3 to 6 weeks. Although
gross lesions developed in multiple organ systems, highest viral titers were detected in skin and in discrete sites within oronasal tissues and
gastrointestinal tract. The temporal distribution of infectious virus and viral DNA in tissues suggests an underlying pathogenesis that is similar to
smallpox and monkeypox where greatest viral replication occurs in the skin. Our data demonstrate that capripoxvirus infections in sheep and goats
provide additional and convenient models which are suitable not only for evaluation of poxvirus-specific vaccine concepts and therapeutics, but
also study of poxvirus–host interactions.
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Sheeppox virus (SPPV) and goatpox virus (GTPV), together
with lumpy skin disease virus (LSDV) of cattle, comprise the
genusCapripoxvirus in the subfamilyChordopoxvirinae, family
Poxviridae (Buller et al., 2005). These viruses are the etiological
agents of sheeppox, goatpox and lumpy skin disease, respec-
tively, which collectively constitute the most serious poxvirus
diseases of production animals (Damon, 2007; Murphy et al.,
1999). SPPV and GTPV cause systemic disease in sheep and
goats that is characterized by fever, generalized skin nodules,
lesions in the respiratory and gastrointestinal tracts and lymph
node enlargement (Kitching, 2004; Kitching and Taylor, 1985a).
Transmission is considered to occur primarily via respiratory
aerosols (Kitching and Taylor, 1985b). However, the potential⁎ Corresponding author. Fax: +61 3 5227 5555.
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doi:10.1016/j.virol.2007.10.002for mechanical transmission by insect vectors has also been
established experimentally (Kitching and Mellor, 1986; Mellor
et al., 1987).
SPPVand GTPVare endemic in Africa (north of the equator),
the Middle East, central Asia and the Indian subcontinent
(Kitching, 2004; Kitching and Carn, 2004), where they have
major impacts on small ruminant production due to the often
high morbidity and mortality associated with disease in
susceptible sheep and goats (Belwal et al., 1982; Bhanuprakash
et al., 2005, 2006; Garner et al., 2000; Kitching et al., 1986,
1987b). In contrast, sheeppox and goatpox are exotic to most
developed countries, for which the inadvertent or deliberate
introduction of disease would have substantial economic rami-
fications due to the disruption to trade in livestock and livestock
products, and the costs associated with disease control and
eradication (Garner and Lack, 1995). Accordingly, sheeppox
and goatpox are categorized as notifiable diseases by the World
Organization for Animal Health (OIE). They are also considered
to be of significance as potential economic bioterrorism agents
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Agents on the National Select Agent Registry. Although effec-
tive live-attenuated vaccine strains are available for control of
disease in sheep and goats (Bhanuprakash et al., 2004; Hosa-
mani et al., 2004b; Kitching, 2003; Kitching et al., 1987a; Roth
and Spickler, 2003), the use of live virus vaccines in non-
endemic countries may not be desirable.
Sheeppox and goatpox are indistinguishable clinically and
strains of SPPV, GTPV and LSDV cannot be differentiated
serologically (Kitching, 1986; Kitching and Taylor, 1985a).
Nevertheless, distinct host preferences exist with most strains
of SPPV and GTPV causing more severe disease in the homo-
logous host (Bhanuprakash et al., 2006; Kitching et al., 1987b;
Kitching and Taylor, 1985a; Sharma et al., 1966; Tantawi et al.,
1980). Notable exceptions are particular capripoxvirus strains
from Africa (Davies, 1976) and the Middle East (Kitching et
al., 1986), each of which appears to be uniformly pathogenic in
sheep and goats. These observations led previously to the
belief that specific isolates of SPPV and GTPV are strains of a
single virus species, with apparent differences in host range a
result of virus-host adaptation within different geographic
regions (Davies and Otema, 1981; Kitching and Taylor,
1985a). Restriction mapping of SPPV, GTPV and LSDV
genomes (Black et al., 1986; Gershon and Black, 1988;
Kitching et al., 1989) and, more recently, phylogenetic studies
based on partial (Hosamani et al., 2004a) and complete
(Tulman et al., 2002) genome sequences suggest, however, that
all three viruses are distinct. In particular, despite the close
genetic relatedness of capripoxvirus isolates, which average no
less than 96% nucleotide identity between strains of SPPV,
GTPV and LSDV, the majority of the observed differences
between species occur in genes that likely determine virulence
and host range (Tulman et al., 2002). Extending these studies
to encompass a wider range of geographic isolates, including
those that cause disease in both sheep and goats, should
facilitate understanding of the genetic basis for specific
virulence and host range characteristics.
Despite the considerable threat that sheeppox and goatpox
pose to small ruminant production, as well as to global trade in
sheep, goats and their products, knowledge of SPPVand GTPV,
and the underlying pathogenesis of the diseases that they cause,
is comparatively rudimentary. Previous studies investigating the
pathology of sheeppox in experimentally infected sheep have
focused primarily on lesion development in the skin (Krishnan,
1968; Murray et al., 1973; Plowright et al., 1959). Nevertheless,
characteristic gross pathology is usually apparent in multiple
other organs as part of the systemic manifestation of disease
(Kitching and Taylor, 1985a). In addition, although experimen-
tal infections in sheep and goats have enabled the qualitative
detection of virus in blood as well as in conjunctival and nasal
secretions (Kitching and Taylor, 1985a,b), no studies regarding
the systemic spread of virus in either sheep or goats have been
previously described. Furthermore, the development of a pro-
minent exanthem (Damon, 2007; Kitching, 2004; Kitching and
Taylor, 1985a) following infection by respiratory aerosol or
contact implies an underlying pathogenesis which parallels that
of smallpox (Fenner, 1988). Although not closely related toorthopoxviruses, capripoxvirus infections in their natural hosts
might therefore provide suitable models with which to study
novel strategies for smallpox virus vaccine and therapeutic
development, particularly since none of the surrogate animal
models currently in use faithfully reproduces all facets of smal-
lpox disease in humans (Jordan and Hruby, 2006; McFadden,
2004).
Here, we describe a quantitative time-course study which
utilized real-time PCR and traditional virological assays to
improve understanding of the pathogenesis of capripoxvirus
infections in sheep and goats. Our results have provided valu-
able insights regarding the nature of acute disease caused by
capripoxviruses in their natural hosts, including the unexpected
observation that some animals shed infectious virus for at least 2
months following the onset of clinical disease.
Results
Sensitivity and specificity of the capripoxvirus real-time PCR
assay
To enable absolute quantitation of viral DNA concentrations
in blood, swab and tissue samples, we developed a quantitative
real-time PCR (qPCR) TaqMan assay to amplify and detect an
89 bp region within ORF074 (Tulman et al., 2001, 2002) of
SPPV, GTPV and LSDV genomes. Primers and probe were
designed following identification of a conserved region within
the 3′ end of this gene by pair wise alignment of all capri-
poxvirus ORF074 sequences available in GenBank (data not
shown). A standard curve was developed by testing 10-fold
serial dilutions of a plasmid template, containing ORF074,
ranging from 106 to 100 copies per triplicate reaction and the
assay was consistently able to detect as few as 10 template
copies (data not shown). This defined the lower limit of the
assay linear dynamic range, which was at least five orders of
magnitude. Although notionally able to detect a single copy of
ORF074, threshold cycle (CT) values for such reactions varied
between 40 and 45. Accordingly, all test samples with CT
values greater than 37 and less than 45 were designated positive,
and assigned a template copy number b10.
The specificity of the capripoxvirus primers and probe was
confirmed initially by performing similarity searches using the
BLAST network service (Altschul et al., 1997). Subsequent
testing of DNA extracted from multiple capripoxvirus and pa-
rapoxvirus (orf) isolates grown in lamb testis cell monolayers,
as well as clinical materials collected from a control sheep and
goat, respectively, demonstrated the capripoxvirus-specific
nature of the assay (data not shown).
Clinical signs and gross pathology in sheep and goats
To facilitate the study of capripoxvirus pathogenesis in small
ruminants, capripoxviruses with predetermined host specificity
for either sheep or goats (Kitching and Taylor, 1985a) were
selected. After a period of acclimatization, nine sheep and nine
goats were inoculated intradermally on a shaved area of the right
chest with either Nigerian SPPV or Indian GTPV, respectively.
Fig. 1. Gross lesions following experimental capripoxvirus infection in sheep and goats. (A) Primary lesion on the lateral thorax of a sheep at DPI 4. The lesion was
well-demarcated, thickened, red and 4 to 5 cm in diameter. The black mark encircling the lesion was applied to the skin at DPI 0 to identify the site of inoculation.
(B) Multifocal papular exanthem on the lateral chest of a goat at DPI 8. Papules (arrowheads) were well-circumscribed, of variable shape, widely distributed and
ranged from several millimeters to 1 to 2 cm in diameter. (C) Multifocal ulcerative enanthem in the soft palate of a goat at DPI 15. Ulcerated lesions (arrowheads) were
well-circumscribed and ranged from several millimeters to 1 to 2 cm in diameter. Similar ulcerated lesions were present on the tongue, nasal mucosa or buccal mucosa
in sheep or goats from DPI 10. (D) Multifocal nodular pneumonia in a goat at DPI 11. Nodules (arrowheads) were pale or red in color, distributed throughout the lung
parenchyma and ranged from several millimeters to 4 to 5 cm in diameter. (E) Multifocal nodular enanthem in the rumen mucosa of a goat at DPI 13. Nodules
(arrowheads) were pale in color, ranged from several millimeters to 1 to 2 cm in diameter and were readily apparent from the serosal surface of the organ. (F) Multifocal
nodular lesions in the liver of a goat at DPI 13. Nodules (arrowheads) were well-circumscribed, pale in color and ranged from pinpoint to 5 mm in diameter.
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second day from day post inoculation (DPI) 4 through to 14, the
severity of the disease in goats resulted, for welfare reasons, in
the unscheduled euthanasia and sampling of two additional goats
between DPI 11 and 15. Consequently, only one goat and three
sheep were available for monitoring and collection of clinical
materials between DPI 15 and the end of the study period at DPI
61 (goat) or DPI 63 to 64 (sheep).
Within 2 to 4 days of virus challenge a well-demarcated,
thickened, erythematous primary lesion of up to 5 cm in
diameter developed at each inoculation site (Fig. 1A). Rectal
temperatures greater than 40 °C, which were indicative of fever,
were first observed by DPI 5 in sheep and by DPI 6 in goats. In
sheep the duration of fever was, on average, 4 to 5 days with a
proportion of sheep showing intermittent low-grade fever for an
additional 4 to 5 days. By contrast, fever in goats was generally
higher than in sheep and persisted for up to 10 days; in addition,Fig. 2. Daily rectal temperatures of sheep and goats infected with Nigerian SPPVor In
first three weeks post inoculation are shown, with error bars indicating standard dev
dashed lines. Note that from DPI 15, data were generated from three sheep and onea second temperature spike of lower magnitude and shorter
duration was observed in the one goat that survived beyond DPI
15 (Fig. 2). In both sheep and goats, the onset of fever coincided
with the development of secondary skin lesions, specifically
erythematous macules several millimeters in diameter, which
faded rapidly and were no longer visible once those animals on
DPI 6 were exsanguinated prior to necropsy. Macules pro-
gressed to papules within 1 to 2 days and, within the following
week, to scabs without either an obvious vesicular or pustular
stage. In the most severely affected animals, papules (Fig. 1B)
were distributed over more than 50% of the skin surface and
were most noticeable in less well-haired or wooled regions
including the axillae, groin, perineum, ventral surface of the tail,
muzzle and ears. By DPI 6 to 8, coincident with the
development of typical pox lesions on mucosal surfaces such
as soft palate (Fig. 1C), nasal mucosa, conjunctiva, tongue and
buccal surface of the lips, other clinical signs such as rhinitis,dian GTPV, respectively. Mean temperatures for all surviving animals during the
iations. The upper limit of the normal temperature range (40 °C) is indicated by
goat, respectively.
Table 1
Distribution of secondary lesions at necropsy in sheep and goats infected with capripoxviruses a
DPI Tissue b
Skin Nasal Pha Ton Eso Tra Lung Rum Abo Ret Cec Liver Kid
4 −,− −,− −,− −,− −,− −,− −,− −,− −,− −,− −,− −,− −,−
6 +,+ −,− −,− −,− −,− −,− +,+ −,− −,− −,− −,− −,− −,−
8 +,+ −,− −,− −,− −,− −,+ +,+ −,− −,− −,− −,− −,− −,−
10 +,+ −,− +,− +,− −,− −,− +,+ −,− −,+ −,− −,− −,− −,−
11 n c,+ n,− n,− n,+ n,− n,+ n,+ n,+ n,+ n,− n,+ n,+ n,+
13 +,+ −,+ −,− −,+ −,− −,− +,+ −,+ +,+ −,− −,− −,+ −,+
15 d +,++ −,−− +,+− +,+− +,−− −,−− +,++ +,++ +,++ +,−+ −,−− −,++ −,+−
a On any given day post inoculation, the presence (+) or absence (−) of secondary lesions in tissues from one sheep and one goat, respectively, are indicated.
b Pha, pharynx; Ton, tongue; Eso, Esophagus; Tra, trachea; Rum, rumen; Abo, abomasum; Ret, reticulum; Cec, cecum; Kid, kidney cortex.
c No sample collected.
d Data are from one sheep and two goats, respectively.
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superficial lymph node enlargement was also observed at this
time and was particularly prominent in prescapular nodes, in
several of which petechiae were noted. In the more severely
affected goats, which were euthanized and necropsied on DPI
11, 13 or 15, nasal secretions became mucopurulent, and
moderate to severe depression was also evident.
Gross lesions in lungs were first apparent by DPI 6 as red
spots on the pleural surface that varied from pinpoint to several
millimeters in diameter. By DPI 8 to 10, readily palpable, pale or
red nodules, up to several centimeters in diameter, were often
present throughout all lung lobes, particularly in those animals
that were most affected clinically (Fig. 1D). A marked abdo-
minal lymphadenopathy was also readily apparent from DPI 6 to
8. In addition, discrete nodules were present in rumen (Fig. 1E),Table 2
Detection of capripoxviruses in blood by qPCR and virus isolation a
Animal no. Day post inoculation
2 4 6 8 10
Sheep 1 −,− −,− n c n n
2 −,− −,− +,− n n
3 −,− −,− −,− 3.8,− n
4 −,− −,− +,− +,− 5.6,+
5 −,− −,− −,− +,− 4.3,−
6 −,− −,− +,− +,+ 4.2,+
7 −,− −,− −,− 4.4,− −,−
8 −,− −,− −,− +,− +,−
9 −,− −,− −,− −,− +,+
Goat 1 −,− −,− n n n
2 −,− −,− +,− n n
3 −,− −,− −,− 4.4,+ n
4 −,− −,− −,− +,+ 4.8,+
5 −,− −,− +,− 5.7,+ 5.3,+
6 −,− −,− +,− +,+ 6.2,+
7 −,− +,− +,− 4.8,+ 5.6,+
8 −,− −,− +,− −,+ +,+
9 −,− −,− −,− +,+ 4.2,+
a On any given day, qPCR and virus isolation data, respectively, are shown for each
“−” indicates the absence of detectable DNA or infectious virus; “+" indicates that the
lamb testis cell monolayers (note that titration of infectivity was not undertaken on
b The goat was sampled on DPI 22, 41 and 61, while the sheep were sampled on
c No sample collected.abomasum or reticulum from DPI 10 in sheep or goats, while
small, well-circumscribed, pale, subcapsular lesions were pre-
sent in the liver (Fig. 1F) and kidney of goats from DPI 11. The
temporal distribution of secondary lesions seen in the six sheep
and eight goats that were necropsied between DPI 4 and 15 is
summarized in Table 1.
Detection of capripoxvirus DNA and infectivity in blood
The kinetics of viremia in capripoxvirus-infected sheep and
goats was assessed initially using real-time PCR to detect viral
genomes and, subsequently, by virus isolation in lamb testis cell
monolayers to confirm the presence of infectious virus. Using
DNA extracted from whole blood, capripoxvirus genomes were
first detected in one of nine goats on DPI 4 and three of eight12 14 21 b 28 42 b 56 64 b
n n n n n n n
n n n n n n n
n n n n n n n
n n n n n n n
+,− n n n n n n
5.9,− 4.5,− n n n n n
+,− +,− −,− −,− −,− −,− −,−
+,− −,− −,− −,− −,− −,− −,−
3.6,− +,− −,− −,− −,− −,− −,−
n n n n n n n
n n n n n n n
n n n n n n n
n n n n n n n
n n n n n n n
5.4,+ n n n n n n
6.0,+ 6.3,+ n n n n n
4.8,+ 5.2,+ n n n n n
5.1,− 4.4,− +,− +,− −,− −,− −,−
sample. Where quantifiable, viral genome copies (log10) per ml are also shown;
genome copy number was below 103.6/ml or that infectious virus was isolated in
blood samples).
DPI 21, 42 and either 63 (Sheep 7) or 64 (Sheep 8 and 9).
Fig. 3. Viral DNA concentrations in tissues collected from capripoxvirus-infected sheep and goats. Viral DNA concentrations were determined by qPCR and are
expressed as log10 viral genome copies per 100 ng of extracted tissue DNA; data are the mean of duplicate reactions with error bars indicating standard deviations.
Tissues that were positive by virus isolation are indicated by a plus (+) symbol and an asterisk (⁎) in x-axis labels denotes that a sample was not collected. Note that the
goat DPI 4 inoculation site and nasal mucosa, the goat DPI 6 abomasum and the sheep DPI 8 and 15 contralateral lymph node samples were not assayed by qPCR. Note
in addition that all qPCR positive samples with fewer than 10 viral genome copies per 100 ng of extracted DNA could not be accurately quantified and were arbitrarily
assigned a value of 0.5 on the y-axis. Abbreviations: LN (lymph node); Normal Skin (skin with no apparent gross pathology); Kidney (kidney cortex).
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Table 3
Quantitation of viral infectivity in goat tissues a
Tissue Day post inoculation
4 6 8 10 11 13
Inoculation site 4.9 6.7 N7.2 N7.2 N7.2 N7.2
Draining LNb − − 4.2 − + +
Liver − − 3.2 − + 4.7
Spleen − − − + + +
Normal skin − 2.7 3.0 4.2 4.4 3.2
Macule n c + n n n n
Papule n n 6.0 7.0 5.2 N7.2
Nasal mucosa − − + + 3.2 2.7
Lung − − 3.2 5.2 3.7 5.2
Bronchial LN − − 2.7 − − +
Ileum − − + − 3.2 3.2
Mesenteric LN − − − + 2.7 −
Tongue − − 5.2 3.7 4.4 5.7
Submandibular LN − − + − − +
Rumen − − − − + −
a On any given day, the viral infectivity in each tissue is shown. Where
quantifiable, viral titers (log10 TCID50/g) are indicated; “−” indicates the
absence of infectious virus; “+” indicates that the titer was below102.7 TCID50/g.
b Lymph node.
c No sample collected.
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positive animals had increased substantially, with the viral
genome copies per ml of blood in 5 of the 12 animals ranging
between 103.8 and 105.7. The viral genetic load in blood peaked
between DPI 10 and 12 in sheep, and between DPI 10 and 14 in
goats. Viral genetic loads during these periods were also ele-
vated in a greater proportion of goats than sheep. Whereas
infectious virus was only isolated in blood from one of seven
sheep on DPI 8 and three of six sheep on DPI 10, viremia was
confirmed by virus isolation in all but two goat samples be-
tween DPI 8 and 14. The infectivity in virus-positive sheep and
goat blood samples was, however, uniformly low in that none of
them generated sufficient viral plaques in lamb testis cell mo-
nolayers to enable titration to be undertaken (data not shown).
Although one surviving goat had viral genomes detectable by
qPCR at DPI 22 and 28, virus could not be detected by qPCR or
virus isolation beyond DPI 14 in sheep or DPI 28 in goats.
Capripoxvirus tropism in solid tissues
The manifestation of pox lesions in skin has long been
recognized as a key feature of disease in sheep and goats caused
by capripoxviruses. Nevertheless, comprehensive studies in-
vestigating the underlying pathogenesis of these diseases have
not been previously reported. To gain a better understanding of
which tissues facilitate virus replication and dissemination in
vivo, we used real-time PCR and virus isolation to identify sites
of virus production in capripoxvirus-infected sheep and goats
that were necropsied at regular intervals between days 4 and 15
post intradermal inoculation. DNA extracted from tissue homo-
genates was first quantified and then its concentration adjusted
such that 100 ng of DNA from each sample was assayed.
Sampling of the primary lesion that developed at the site of
inoculation revealed substantial concentrations of viral genome
in sheep and goats by DPI 4 to 6 (approximately 107 viral
genomes per 100 ng of extracted DNA), which increased gra-
dually to 108 genomes per 100 ng of extracted DNA by DPI 15
in sheep or DPI 13 in goats (Fig. 3). Infectious virus was also
readily isolated from the skin inoculation site on all days sam-
pled. On DPI 4, low concentrations of viral DNA (fewer than
102 genomes per 100 ng of extracted DNA) were detected in
sheep and goat lung, as well as in a small number of other
tissues of either sheep or goat origin. By DPI 6, viral DNAwas
detected in multiple organs with highest concentrations occur-
ring in apparently normal sheep skin and goat tongue (approx-
imately 104 genomes per 100 ng of extracted DNA). In contrast,
infectious virus was only recovered from goat skin on DPI 6,
with positive samples including those that were either grossly
normal or exhibiting macular lesions. From DPI 8, viral DNA
and infectious virus were recovered from an increasing range of
tissues, including those from the respiratory and gastrointestinal
tracts as well as lymph nodes. However, the highest concentra-
tions of viral DNAwere consistently detected at the inoculation
site (107 to 108 genomes per 100 ng of extracted DNA) and in
secondary skin lesions (106 to 108 genomes per 100 ng of
extracted DNA) and, to a lesser extent, in lung (102 to 106
genomes per 100 ng of extracted DNA). Although infectiousvirus was recovered from most other tissues beyond DPI 8, the
viral DNA concentration in these tissues was generally below
102 to 103 genomes per 100 ng of extracted DNA. Several
tissues had concentrations of viral DNA greater than or approxi-
mately equal to 106 genomes per 100 ng of extracted DNA on
one or more days, including tongue on DPI 10 and 15 (sheep)
and DPI 11 and 13 (goat), draining lymph node on DPI 13
(sheep), liver on DPI 13 (goat) and rumen on DPI 15 (sheep).
With the exception of the draining lymph node, these samples
were from discrete lesions such as those depicted in Fig. 1.
Selected goat tissues were subsequently homogenized and
titrated on replicate lamb testis cell monolayers to determine viral
titers (Table 3). The titer at the inoculation site increased from
DPI 4 (104.9 TCID50/g) to DPI 8 (greater than 10
7.2 TCID50/g).
Similarly, moderate to high viral titers were detected consistently
in apparently normal skin (102.7 to 104.4 TCID50/g) and in
secondary skin lesions (less than 102.7 to greater than 107.2
TCID50/g) from DPI 6, in lung (10
3.2 to 105.2 TCID50/g) and
tongue (103.7 to 105.7 TCID50/g) from DPI 8, and, to a lesser
extent, in nasal mucosa and ileum on DPI 11 and 13. Infectious
virus was detectable in spleen on DPI 10, 11 and 13, but it was
not of a sufficiently high titer to permit quantitation. In contrast,
moderate titers of virus were present in liver on DPI 8 and 13. Of
note, even though there were moderate to high viral titers in skin,
nasal mucosa, lung, tongue and ileum on two or more days,
infectious virus was only detected inconsistently at low to
moderate levels in the lymph nodes that drained these regions.
Kinetics of capripoxvirus shedding from mucosal surfaces
To investigate virus shedding from mucosal surfaces, various
swabs and urine, collected at different stages throughout the
study, were screened firstly by qPCR, to quantify viral genomes,
and, subsequently, by titration of infectivity in replicate lamb
Table 4
Kinetics of virus shedding from mucosal surfaces measured by qPCR and virus isolation a
Swab Animal
no.
Day post inoculation
2 4 6 8 10 12 14 21 b 28 42 b 56 64 b
Nasal Sheep 1 −,− −,− n c n n n n n n n n n
2 −,− −,− −,− n n n n n n n n n
3 −,− −,− +,− 5.1,+ n n n n n n n n
4 −,− −,− +,− +,+ 6.2,3.0 n n n n n n n
5 −,− −,− +,− +,+ 4.4,2.2 +,+ n n n n n n
6 −,− −,− −,− +,+ 5.0,2.2 4.6,+ 4.5,3.2 n n n n n
7 −,− −,− −,− +,+ 3.5,1.7 +,+ +,1.7 3.6,2.0 3.5,+ 3.7,+ +,+ −,+
8 −,− −,− −,− −,+ +,2.2 +,+ 5.1,+ −,+ +,+ 3.4,+ +,+ +,+
9 −,− −,− −,− +,+ +,1.7 +,+ +,+ 3.6,+ +,+ +,+ +,+ −,+
Goat 1 −,− −,− n n n n n n n n n n
2 −,− −,− +,− n n n n n n n n n
3 −,− −,− +,− +,− n n n n n n n n
4 −,− −,− −,− −,− 5.3,− n n n n n n n
5 −,− −,− −,− +,− 5.7,− n n n n n n n
6 −,− −,− −,− +,− 6.0,4.2 4.9,3.0 n n n n n n
7 −,− −,− −,− +,− 4.2,− 5.0,− 6.4,2.7 n n n n n
8 −,− −,− −,− +,− n,+ 6.2,+ 5.6,+ n n n n n
9 −,− −,− −,− −,− −,− +,+ +,+ +,+ +,+ +,+ +,− −,−
Con d Sheep 1 −,− −,− n n n n n n n n n n
2 −,− −,− −,− n n n n n n n n n
3 −,− −,− −,− +,+ n n n n n n n n
4 −,− −,− −,− 3.6,− 5.1,+ n n n n n n n
5 −,− −,− −,− −,− 4.4,+ −,+ n n n n n n
6 −,− −,− −,− 4.2,− 3.8,+ 4.4,+ 4.3,+ n n n n n
7 −,− −,− −,− −,− +,+ +,+ +,− +,3.2 3.8,+ +,+ +,− −,−
8 −,− −,− −,− −,− −,− +,+ 4.7,− +,+ +,+ 3.9,+ +,− −,−
9 −,− −,− −,− −,− +,+ −,+ +,− +,+ +,+ +,+ +,− −,−
Goat 1 −,− −,− n n n n n n n n n n
2 −,− −,− −,− n n n n n n n n n
3 −,− −,− −,− −,− n n n n n n n n
4 −,− −,− −,− +,− 4.7,2.5 n n n n n n n
5 −,− −,− −,− +,− 4.2,− n n n n n n n
6 −,− −,− −,+ 3.8,+ 6.0,3.0 6.4,4.2 n n n n n n
7 −,− −,− −,− −,− 5.3,3.2 6.0,4.4 7.0,5.0 n n n n n
8 −,− −,− −,− −,− n,− +,− +,− n n n n n
9 −,− −,− −,− −,− +,− 5.5,− +,+ +,+ −,− +,− +,− +,−
Oral Sheep 1 −,− −,− n n n n n n n n n n
2 −,− −,− −,− n n n n n n n n n
3 −,− −,− +,− 4.3,+ n n n n n n n n
4 −,− −,− +,+ 4.2,+ 5.5,2.4 n n n n n n n
5 −,− −,− −,− +,− +,+ 4.7,1.7 n n n n n n
6 −,− −,− −,− +,+ +,+ 3.7,+ 3.4,− n n n n n
7 −,− −,− −,− 3.6,− 5.3,+ 4.1,− 3.7,1.7 4.9,+ 4.2,+ +,− −,− −,−
8 −,− −,− +,− +,− +,+ 5.2,+ 5.8,1.7 3.6,− +,− +,− −,− −,−
9 −,− −,− −,− +,− 3.5,1.7 3.7,+ 3.5,− 3.5,− −,− +,− −,− −,−
Goat 1 −,− −,− n n n n n n n n n n
2 −,− −,− −,− n n n n n n n n n
3 −,− −,− −,− +,− n n n n n n n n
4 −,− −,− +,− +,− 3.4,− n n n n n n n
5 −,− −,− −,− −,− 5.3,2.4 n n n n n n n
6 −,− −,− −,− +,− 5.1,2.4 3.8,+ n n n n n n
7 −,− −,− −,− +,− 5.1,+ 5.1,2.2 6.2,3.7 n n n n n
8 −,− −,− −,− +,− n,− 3.7,+ 4.9,+ n n n n n
9 −,− −,− −,− −,− 3.5,− +,1.7 3.8,+ 4.4,+ 4.8,− 4.1,− 3.7,− +,−
a On any given day, the viral genetic load and viral infectivity in each sample, determined by qPCR and virus isolation, respectively, are shown. Where quantifiable,
viral genome copies (log10) and viral titers (log10 TCID50) per ml of viral transport medium, into which swabs were collected, are also shown; “−” indicates the absence
of detectable DNA or infectious virus; “+” indicates either that the genome copy number was below 103.4/ml or that the titer was below 101.7 TCID50/ml.
b The goat was sampled on DPI 22, 41 and 61, whereas the sheep were sampled on DPI 21, 42 and either 63 (Sheep 7) or 64 (Sheep 8 and 9).
c No sample collected.
d Conjunctival.
386 T.R. Bowden et al. / Virology 371 (2008) 380–393
Table 5
Detection of virus in rectal swabs and urine at necropsy a
Sample Animal Day post inoculation
4 6 8 10 11 13 15 b 61 63 64b
Rectal
swab
Sheep −,− −,n c −,+ 3.5,− n,n n,− 3.4,− n,n −,− −,−
−,−
Goat +,n +,− −,+ +,+ +,+ −,+ 7.4,+ +,− n,n n,n
4.1,+
Urine Sheep −,− −,− −,− 3.4,− n,n −,− 3.9,+ n,n −,− n,−
n,−
Goat −,n n,n n,− −,− −,− −,− −,− −,− n,n n,n
−,−
a On any given day, the viral genetic load and viral infectivity in each sample,
determined by qPCR and virus isolation, respectively, are shown. Where
quantifiable, viral genome copies (log10) and viral titers (log10 TCID50) per ml of
viral transport medium, into which swabs were collected, or urine, respectively,
are also shown; “−” indicates the absence of detectable DNA or infectious virus;
“+” indicates either that the genome copy number was below 103.4/ml or that the
titer was below 101.7 TCID50/ml of each respective sample type.
b Two goats or two sheep were sampled on DPI 15 and 64, respectively.
c No sample tested.
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umes of each swab or urine sample was used as template for
qPCR. The accumulation of viral DNA or infectious virus in
nasal, conjunctival and oral secretions was first detected in most
animals by DPI 6 to 8, peaked between DPI 10 and 14 and
declined rapidly thereafter (Table 4). Of particular note, in-
fectious virus was detected in nasal secretions of every sheep
sampled between DPI 8 and 64, albeit at low levels (less than
101.7 TCID50/ml of viral transport medium) from DPI 21. Low
level viral shedding in nasal secretions was also observed in the
only goat to survive beyond DPI 15, with infectious virus in this
animal detectable from DPI 12 through to DPI 41. A similar
pattern of extended shedding was observed in conjunctival and
oral samples, with infectious virus detectable in conjunctival
swabs from three of three sheep until DPI 42 and from one goat
until DPI 22, and in oral swabs from one of three sheep until
DPI 28 and from one goat until DPI 22.
The recovery of viral DNA and infectious virus from rectal
swabs and urine, collected during necropsy, was less consistent
(Table 5). For rectal swabs, infectious virus was recovered from
goats that were necropsied between DPI 8 and 15, whereas viral
DNA was detected as early as DPI 4 and as late as DPI 61 by
qPCR. For sheep, infectious virus was only recovered from
rectal swabs on DPI 8, with samples collected on DPI 10 and 15
positive by qPCR. No viral DNA or infectious virus was re-
covered from the urine of any goat. However, viral DNA was
detected in sheep urine on DPI 10 and 15, with the later sample
also positive by virus isolation. Nevertheless, the infectivity of
all virus-positive rectal swabs and urine specimens was low
(below 101.7 TCID50/ml of viral transport medium or urine,
respectively).
Discussion
This study confirmed the relative ease of producing systemic
capripoxvirus infections in sheep and goats, by intradermal
inoculation, using tissue culture passaged virus. Two distinctvirus isolates were used, specifically Nigerian SPPVand Indian
GTPV, which were selected on the basis that each has a clear
specificity for causing disease in sheep or goats, respectively
(Kitching and Taylor, 1985a). The clinical signs and gross
pathology that developed following experimental infection of
sheep and goats were comparable, and were also consistent with
previous descriptions of sheeppox and goatpox caused by these,
and other, capripoxvirus isolates (Kitching et al., 1986, 1987b,
1989; Kitching and Taylor, 1985a). Notably, the morbidity in
goats infected with Indian GTPV was more severe than that in
sheep infected with Nigerian SPPV. In this regard, the increased
severity of disease in goats was characterized by: fevers of
greater duration and magnitude; more consistent and longer
lasting viremia; development of profuse, mucopurulent nasal
discharges; excessive salivation; development of moderate to
marked depression; the presence, later in the disease course, of
gross lesions in a greater range of viscera at necropsy; and the
unscheduled euthanasia, on welfare grounds, of additional goats
between DPI 11 and 15. An explanation for the apparent dif-
ferences in pathogenicity of each isolate was not investigated as
part of this study, but could be attributed to one or more factors
including the passage history of each inoculum, the intrinsic
virulence of the virus isolates, the genetic susceptibility of the
animals and the route of inoculation. Although we were unable
to determine mortality rates for either capripoxvirus isolate,
previous experiments using Nigerian SPPV or Indian GTPV
resulted inmortalities of 75 to 100% depending on the host breed
and dose of inoculum (Kitching and Taylor, 1985a). Neverthe-
less, the disease in sheep and goats was clearly systemic, which
enabled a detailed, quantitative analysis of capripoxvirus dis-
semination and shedding to be undertaken using real-time PCR
to determine viral DNA concentrations in clinical specimens,
followed by virus isolation to confirm sample infectivity.
Although transmission of sheeppox and goatpox is believed
to occur primarily via respiratory aerosol, the difficulty in pre-
cisely synchronizing the experimental infection of sheep and
goats by this method (Kitching and Taylor, 1985b) led us to
inoculate animals intradermally instead. Inoculation of capri-
poxviruses into the dermis is recognized as an efficient means
by which to experimentally infect sheep and goats (Davies,
1976; Kitching et al., 1986, 1987b, 1989; Kitching and Taylor,
1985a) and, apart from a shorter incubation period, results in
clinical disease that closely resembles that seen following
successful infection by aerosol or by spread from infected to
susceptible, in-contact animals (Kitching and Taylor, 1985a,b).
The incubation period which, in this study, we defined as the
interval from intradermal inoculation to onset of fever, was 5 to
6 days in sheep and goats. The end of the incubation period
coincided with the onset of measurable viremia, for which the
presence of viral DNA, first detected by qPCR on DPI 4 in goats
or DPI 6 in sheep, preceded the isolation of infectious virus in
sheep and goats by 1 to 2 days. However, although virus clearly
replicated at the inoculation site and in multiple tissues remote
to the primary lesion that developed at this site, the tissues
which contributed principally to the development of viremia
could not be identified. Even though very low concentrations of
viral DNA could be detected in the lymph node draining the
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infectious virus could not be recovered from this node until DPI
8 in either sheep or goats. Furthermore, no infectious virus was
recovered from any organ distant to the inoculation site on DPI
4, despite the fact that viral DNA could be detected at low
concentrations (fewer than 10 genome copies per 100 ng of
extracted DNA) in multiple organs, as well as in lung (approxi-
mately 102 genome copies per 100 ng of extracted DNA). A
slightly higher viral DNA concentration in sheep and goat lung
on DPI 4 suggests that this might be one of multiple organs
which were infected during the primary viremia that must have
occurred prior to DPI 4. Nevertheless, infectious virus could not
be recovered in tissues, other than skin, until DPI 8. Beyond
DPI 8, viral DNA and infectious virus could be detected in most
tissues, with highest concentrations of DNA present in skin
(exceeding 106 genome copies per 100 ng of extracted DNA)
and, to a lesser extent, lung (approximately 103 to 106 genome
copies per 100 ng of extracted DNA). Several other tissues had
concentrations of viral DNA that were comparable to that seen
in skin but, apart from the draining lymph node collected from a
sheep on DPI 13, these were invariably associated with discrete
pox lesions in tongue, rumen or liver. The low concentrations of
viral DNA (fewer than 102 genome copies per 100 ng of
extracted DNA) that were consistently detected between DPI
8 to 15 in spleen, which is a well-perfused organ, probably
reflect the maximum viral genetic load that could be attributed
to viremia alone. Accordingly, the slightly higher viral DNA
concentrations (approximately 103 genome copies per 100 ng of
extracted DNA) in various tissues, including those of lymphoid
origin, suggest that they might also be target sites for virus
replication. Of particular note, however, was the conspicuous
absence of histological lesions in liver and spleen prior to DPI
10 (data not shown), as well as the low viral genetic loads and
infectivity in these organs. These observations demonstrate that
the pathogenesis of sheeppox and goatpox is substantially
different to that of mousepox, in which there is extensive re-
plication and necrosis in liver and spleen prior to widespread
seeding of virus to the skin (Fenner, 1948a,b). Nevertheless, our
data confirm the tropism of SPPVand GTPV for skin and lung,
as well as discrete sites within mucosal surfaces of oronasal
tissues and the gastrointestinal tract, and, to a lesser extent,
lymphoid tissues.
Although we did not investigate the nature of the viremia in
this study, the previously reported infectivity of buffy coats
(Kitching and Taylor, 1985a) suggests that it is cell-associated.
More recently, immunohistochemical studies in skin and lung of
naturally infected lambs have confirmed that the majority of
virus-infected cells in the inflammatory infiltrates are in fact
virus-infected monocytes and macrophages (Gulbahar et al.,
2006). By analogy with the monocyte-associated viremia that
has been observed in monkeys infected with either monkeypox
virus (Zaucha et al., 2001) or variola virus (Jahrling et al.,
2004), we suggest that dissemination of SPPV and GTPV from
the primary lesion to the draining lymph node, and then to the
systemic circulation, with localization to skin and other tissues,
is therefore also likely to occur through infected monocytes and
macrophages. It is clearly of interest to examine all tissueshistologically to further define the cellular tropism of these
viruses, both during and after the incubation period, and these
studies are currently in progress.
The onset of virus shedding in nasal, conjunctival and oral
secretions occurred in most animals between DPI 6 to 10 and
correlated with the appearance of ulcerated lesions on asso-
ciated mucosal surfaces, most probably resulting from hema-
togenous spread to these tissues. Peak shedding of viral DNA
and infectious virus in each sample type occurred between DPI
10 and 14 and declined rapidly thereafter. In all cases, the
highest infectious titers in nasal, conjunctival and oral swabs
were observed in goats, and correlated with the greater severity
of clinical signs in these animals. Nevertheless, despite the
development of virus neutralizing antibodies in sheep and goat
sera by DPI 10 to 14 (data not shown), virus was shed at low
concentrations in nasal secretions until DPI 64 in sheep or 41 in
goats, conjunctival secretions until DPI 42 in sheep or 22 in
goats, and oral secretions until DPI 28 in sheep or 22 in goats.
Furthermore, virus shedding was also detected at low levels in
urine and feces between DPI 8 and 15, with the higher pro-
portion of positive goat rectal swabs presumably also a reflec-
tion of the more severe disease in these animals. Conceivably,
all such secretions and excretions could contribute to virus
transmission either directly by aerosol, in the case of nasal and
oral secretions, or indirectly by contamination of the environ-
ment. Although such extended shedding has not been reported
previously for SPPV or GTPV isolates, shedding in semen has
been observed for as long as 42 days following inoculation of
bulls with LSDV (Irons et al., 2005). In addition, shedding of
ectromelia virus in mice has been observed from tail lesions or
in feces for up to 116 days following oral inoculation (Gledhill,
1962), and in feces for up to 47 days or from skin for up to
60 days following intragastric inoculation (Wallace and Buller,
1985). Similar extended periods of virus shedding have not
been reported for other poxviruses. Even so, our findings con-
trast with a previous report by Kitching and Taylor (1985b),
who were unable to isolate infectious virus from nasal swabs
beyond the twelfth day after the onset of fever in sheep that had
been infected by aerosol or contact with a capripoxvirus isolate
from Yemen. Based on these apparently conflicting observa-
tions, it would be of considerable interest to extend these in-
vestigations in sheep and goats that have been inoculated either
intradermally or by inhalation. Although the source of virus for
the extended shedding from mucosal surfaces was not identified
in our studies, it is plausible that replication and shedding might
occur at specific mucosal sites without marked lesion devel-
opment, as is thought to take place in the upper respiratory tract
of some human vaccinees who are subsequently exposed to
variola virus (Fenner, 1988). Evidence for this hypothesis might
be obtained by detailed histopathological and immunohisto-
chemical examination of these sites, and this work is in progress.
Sheeppox and goatpox are classically considered to be trans-
mitted by contact and inhalation (Kitching and Taylor, 1985b).
However, in view of the very high viral titers in skin, the
importance of mechanical transmission by biting insects may
well be greater than previously suspected. For lumpy skin dis-
ease, direct contact between cattle is not considered an important
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biting flies and mosquitoes are considered responsible for dis-
ease spread (Carn and Kitching, 1995a; Chihota et al., 2001;
Woods, 1988), and good epidemiological evidence exists to
support this notion (Woods, 1988; Yeruham et al., 1995). My-
xoma virus (Day et al., 1956; Fenner et al., 1952) and avipox-
viruses (Damon, 2007; Murphy et al., 1999; Tripathy and Reed,
2003) are transmitted mechanically by biting insects and mos-
quitoes, and experimental transmission of SPPV and GTPV by
biting flies has been documented (Kitching and Mellor, 1986;
Mellor et al., 1987). Nevertheless, further experimental and
epidemiological investigations in sheep and goats will be re-
quired to clarify the involvement of insect vectors in the spread
of SPPV and GTPV.
The pathogenesis and tissue tropism of capripoxvirus infec-
tions in sheep and goats observed here are in marked contrast to
that seen with ectromelia virus in mice, which is the model most
often used in pathogenesis and immunological studies of acute
poxvirus diseases of animals (Buller and Palumbo, 1991). The
tropism of SPPVand GTPV for the skin, as well as the apparent
minor involvement of liver and spleen, instead suggests a pa-
thogenesis which more closely resembles that of smallpox and
monkeypox (Fenner, 1988; Jahrling et al., 2004; Zaucha et al.,
2001). Although only detected in one goat, the less pronounced
second temperature spike which occurred beyond DPI 17 also
resembles that seen in humans with smallpox, especially in
patients with secondary bacterial infections (Breman and Hen-
derson, 2002). A striking feature of sheeppox and goatpox,
however, is the generalized and prominent lymphadenopathy
that develops at or shortly after the onset of clinical disease, and
which is analogous to that seen with monkeypox virus infec-
tions in humans (Di Giulio and Eckburg, 2004; Huhn et al.,
2005; Jezek and Fenner, 1988) as well as lumpy skin disease in
cattle (Carn and Kitching, 1995b). In sheeppox and goatpox,
this appears to occur in the absence of substantial virus repli-
cation, which suggests unique underlying viral or immunolog-
ical mechanisms might be involved.
While vaccines and control strategies used for eradication of
smallpox were effective for their time, the vaccines no longer
appear acceptable for large scale emergency vaccination. Fur-
thermore, although there are now several candidate antiviral
drugs that appear suitable for mass protection against a possible
global smallpox pandemic arising from an act of bioterrorism
(Bailey et al., 2007; Painter and Hostetler, 2004; Quenelle et al.,
2004, 2007; Sbrana et al., 2007; Yang et al., 2005), regulatory
approval for their use in humans has not yet been completed.
Since none of the surrogate animal models currently in use
faithfully reproduces all aspects of smallpox disease in humans,
there is a need for additional model systems to test alternative
vaccine and therapeutic strategies (Jordan and Hruby, 2006;
McFadden, 2004). Non-human primates are potentially useful
models for variola virus infection in humans (Jahrling et al.,
2004). However, limited access to animals, welfare concerns
and the greater costs of housing and containment suggest that
poxviruses of other species should also be considered for initial
concept development. Conceivably, it would be possible to
introduce drug target genes from orthopoxviruses into the cap-ripoxvirus genome by way of recombinant virus construction
(Romero et al., 1993) and thus directly evaluate, in sheep or
goats, the potential efficacy of therapeutic drug candidates.
Additionally, the identification of potential capripoxvirus anti-
gens for subunit vaccine development may provide guidance to
suitable candidates for evaluation and development of ortho-
poxvirus vaccines. Other intervention strategies targeting the
cytokine storm precipitated during acute poxvirus disease (Stan-
ford et al., 2007) or specific poxvirus-encoded immunomodu-
latory proteins (Johnston andMcFadden, 2003; Seet et al., 2003;
Smith and Kotwal, 2002) might also be explored using capri-
poxvirus infections in sheep and goats.
Our studies have revealed novel insights regarding the repli-
cation, dissemination and shedding of capripoxviruses in sheep
and goats, the pathogenesis of which has more in common with
smallpox and monkeypox in humans than ectromelia in mice.
The extensive involvement of skin, with its associated high
infectivity, suggests that mechanical transmission by biting
insects might be more significant in disease spread than pre-
viously thought. Furthermore, long-term shedding of virus from
mucosal surfaces, particularly in nasal and conjunctival sec-
retions, illustrates the potential for some animals, at least, to
remain infectious for up to 2 months after the onset of fever.
These findings should enable the development of improved
strategies for capripoxvirus detection and disease control. The
simple reproduction of acute disease in sheep and goats,
together with the reduced hazards associated with handling
SPPV or GTPV over variola virus or monkeypox virus, also
support the potential application of capripoxviruses to the study
of novel poxvirus therapeutic and vaccine strategies.
Materials and methods
Animal housing and husbandry
Ten adult Suffolk-cross sheep and ten adult Saanen or Alpine
goats were housed in microbiologically secure (Biosecurity
level 3) animal rooms at the National Centre for Foreign Animal
Disease (NCFAD), Winnipeg, Canada. Following the euthana-
sia and necropsy of one sheep and one goat for collection of
uninfected control swab and tissue samples, sheep and goats
were housed in groups of three until such time as additional
animals were sacrificed for necropsy and sample collection.
Animals were fed a complete balanced diet and water ad
libitum, and all experimental procedures, which complied with
Canadian Council on Animal Care guidelines, were approved
by the Animal Care Committee of the Canadian Science Centre
for Human and Animal Health.
Virus isolates
Capripoxviruses were obtained from the Institute for Animal
Health (Pirbright Laboratory, Pirbright, Surrey, UK). The pas-
sage history of each isolate prior to inoculation of experimental
animals was as follows: Nigerian SPPV was isolated in 1977
(Asagba and Nawathe, 1981) and was subsequently passaged
three times in lamb testis cells at the Institute for Animal Health
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NCFAD; Indian GTPV was isolated in 1983 and was sub-
sequently passaged once in lamb testis cells at the Institute for
Animal Health (Kitching and Taylor, 1985a) and twice in lamb
testis cells at NCFAD. Neither isolate was plaque-purified.
Inoculation of animals, monitoring and sample collection
Animals were inoculated intradermally, in a shaved area on
the right chest, with either 104.9 50% tissue culture infectious
doses (TCID50) of Nigerian SPPV (sheep) or 10
4.4 TCID50 of
Indian GTPV (goats). Each day rectal temperatures were re-
corded and animals were examined for clinical signs, including
the development of lesions at the inoculation site and elsewhere
on the body.
On DPI 2, 4, 6, 8, 10, 12, 14, 21, 28, 42 and 56, and at the
conclusion of the experiment (DPI 61 for goats or DPI 63 to 64
for sheep), whole blood was collected into EDTA Vacutainer
tubes (Becton-Dickenson, Franklin Lakes, NJ, USA) and nasal,
conjunctival and oral swabs were collected and placed into
1.25 ml of viral transport medium (phosphate buffered saline
containing 1% (w/v) bovine serum albumin, 200U/ml penicillin,
200 μg/ml streptomycin, 50 μg/ml gentamicin and 5 μg/ml
amphotericin B). These samples were stored immediately on wet
ice (4 °C) while sampling was in progress. Subsequently, ali-
quots of EDTA blood (50 μl) and swabs (100 μl) were pipetted
into 300 μl of Lysis/Binding buffer (Roche, Laval, QC, Canada)
and stored at −20 °C prior to extraction of DNA, whereas the
remainder of each sample was transferred to −80 °C prior to
virus isolation.
On DPI 4, 6, 8 and 10, one sheep and one goat were
euthanized by barbiturate overdose and necropsied. Thereafter
one additional sheep on DPI 13 and 15, one additional goat on
DPI 11 and 13, and two additional goats on DPI 15 were also
euthanized and necropsied. Prior to euthanasia, animals were
routinely anaesthetized by intramuscular administration of atro-
pine sulfate (0.05 mg/kg; Atropine Injection; MTC Pharmaceu-
ticals, Cambridge, ON, Canada) followed by intravenous
administration of xylazine HCl (0.05–0.1 mg/kg; Rompun;
Bayer, Toronto, ON, Canada) and ketamine HCl (5.0–10mg/kg;
Ketaset; Ayerst Veterinary Laboratories, Guelph, ON, Canada),
and partially exsanguinated by jugular catheterization.
To eliminate risks of cross contamination between necropsy
samples, substantial precautions were taken during specimen
collection and processing. These included the use of separate
sterile scissors and forceps to access all tissues sampled, and the
harvesting of tissues onto individual sterile disposable petri
dishes for further processing with separate sterile disposable
forceps and scalpels. Urine, collected by cystocentesis, and
rectal swabs were also taken at necropsy. Tissue samples for
virus isolation were collected in sterile 2 ml screw cap tubes
(Sarstedt, Nümbrecht, Germany). Tissue samples for DNA ex-
traction (no bigger than 125 mm3) were stored in 1.25 ml of
RNAlater (Ambion, Austin, TX, USA), initially at 4 °C over-
night, followed by −20 °C thereafter, whereas aliquots of urine
(100 μl) and rectal swabs (100 μl) were pipetted into 300 μl of
Lysis/Binding buffer (Roche, Laval, QC, Canada) and stored at−20 °C prior to extraction of DNA. To ensure sample integrity,
all specimens were collected onto wet ice during the necropsy
and replicate samples for virus isolation were subsequently
transferred to −80 °C for long-term storage. All samples for
DNA extraction were inactivated by gamma irradiation (20 kGy)
before shipment to the Australian Animal Health Laboratory,
Geelong, Victoria, Australia.
DNA extraction
DNA from all clinical materials was extracted using the
MagNA Pure LC System (Roche, Melbourne, Victoria, Aus-
tralia), an automated nucleic acid isolation and purification
platform, according to the recommendations of the manufactur-
er. DNA from blood, urine or swab material, mixed with MagNa
Pure Lysis/Binding buffer, was extracted using a MagNA Pure
DNA I kit and eluted in 100 μl of the provided Elution buffer.
DNA from RNAlater stored tissues was extracted using the
MagNA Pure DNA II kit following an overnight proteinase K
digestion. Briefly, 20 to 30 mg of each tissue was homogenized
in 240 μl of MagNA Pure DNA II kit Tissue Lysis buffer using
the MagNA Lyser instrument (Roche, Melbourne, Victoria,
Australia). Samples were subjected to two 25 s periods of
homogenization at 6500 rpm with 90 s cooling between cycles.
Proteinase K (Roche, Melbourne, Victoria, Australia) was added
to a final concentration of 3 mg/ml and the samples were
incubated at 56 °C overnight on an orbital shaker. RNase A
(Roche, Melbourne, Victoria, Australia) was added to a final
concentration of 3.5 mg/ml and the samples were further
incubated for 15 min at 65 °C. Samples were clarified in a bench
top microcentrifuge at 13,000 rpm for 1 min, after which DNA
was extracted from 110 μl of supernatant using the MagNA Pure
DNA II kit external lysis protocol and eluted in 200 μl of Elution
buffer. DNA concentrations of each eluate were determined
using the GeneQuant II RNA/DNA Calculator (GE Healthcare
Life Sciences, Castle Hill, NSW, Australia) and adjusted to
20 ng/μl with nuclease free water (Promega,Madison,WI, USA)
prior to viral genome quantitation by real-time PCR.
Quantitative real-time PCR
A quantitative real-time PCR (qPCR) TaqMan assay that
amplified and detected an 89 bp region within SPPV, GTPVand
LSDV ORF074 (Tulman et al., 2001, 2002), which encodes the
intracellular mature virion envelope protein P32 (vaccinia virus
H3L homolog), was used to determine viral genetic loads in
clinical samples. Duplexed detection of either an endogenous
control (TaqMan rRNA Control Reagents, Applied Biosystems,
Scorseby, Victoria, Australia), for solid tissues, or an exogenous
control (TaqMan Exogenous IPC Reagents, Applied Biosys-
tems), for blood, swabs and urine, provided a means of verifying
the absence of PCR inhibitors in samples tested. For
amplification of target sequences, the TaqMan Universal PCR
Master Mix Kit (Applied Biosystems) was used. The capri-
poxvirus-specific primers and probe were designed using the
Applied Biosystems Primer Express software (version 2) using
the default design parameters. Primers CaPV-074F1 5′-AAA
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074R1 5′-AAA TGA AAC CAA TGG ATG GGA TA-3′ were
used in conjunction with the minor groove binder (MGB)
TaqMan probe CaPV-074P1 5′-6FAM-TGG CTC ATA GAT
TTC CT-MGBNFQ-3′. The reactions were performed in 96-
well Optical Reaction Plates (Applied Biosystems) and, for
extracted solid tissues, contained 12.5 μl TaqMan Universal
PCRMaster Mix, 900 nM of each capripoxvirus primer, 250 nM
of capripoxvirus probe, 50 nM of each 18S rRNA primer,
200 nM of 18S rRNA probe, 5 μl (100 ng) of template and water
to 25 μl. For extracted blood, urine and swab specimens which,
in contrast to templates derived from solid tissues, contained
very low concentrations of DNA, reactions were set up similarly
except that the rRNA primers and probe were replaced with
0.5 μl 50× IPC DNA (a synthetic plasmid template) and 2.5 μl
10× Exo IPC mix (containing the corresponding primers and
probe). Rather than amplification of the endogenous 18S rRNA
gene, such reactions relied on the multiplexed quantitation of an
exogenous, synthetic DNA target for confirming the absence of
inhibitors. The reactions were run on the ABI PRISM 7700
Sequence Detection System (Applied Biosystems) using the
following amplification program: 50 °C for 2 min; 95 °C for
10 min; and 45 cycles of 95 °C for 15 s and 60 °C for 1 min.
Results were generated by determination of the threshold cycle
(CT), the fractional cycle number at which the change in the
fluorescence (ΔRn) of each reporter dye passed a fixed threshold
value set in the log (exponential) phase of amplification. For all
reactions, the baseline was routinely set between cycles 3 and 15,
while the threshold ΔRn values were set at 0.15 for capripox-
virus-specific products and either 0.1 or 0.05 for products derived
from the endogenous or exogenous controls, respectively.
For absolute quantitation of viral genetic loads in samples
tested, a standard curve was developed by assaying 10-fold
serial dilutions, ranging from 106 to 10 copies, of a pDONR221
plasmid (Invitrogen, Mount Waverley, Victoria, Australia) con-
taining the full open reading frame of gene 074. The plasmid
(pDONR221-S074) was linearized by digestion with PvuI
(New England Biolabs, Beverly, MA, USA), gel-purified and
diluted in herring sperm DNA (Promega, Madison, WI, USA) at
5 ng/μl to ensure a uniform background of DNA at all template
concentrations used. Quantitative standards were always in-
cluded in triplicate on each reaction plate, whereas sample
reactions were routinely conducted in duplicate. Viral genome
copies per 100 ng of extracted tissue DNAwere calculated with
reference to the plasmid standard curve, and tissue samples
containing very high genome copies were diluted before assay if
necessary. For blood, urine and swabs, the genome copy num-
bers were calculated and expressed as copies per milliliter of
each respective sample type. The lower limit of the standard
curve linear dynamic range was 10 copies of pDONR221-S074,
which equated approximately to a CT value of 37. Sample
templates with CT values greater than 37 and less than 45 were
considered positive (containing fewer than 10 genome copies
per well) but could not be precisely quantified. All such samples
corresponded to viral genome copy numbers b10 per 100 ng of
extracted DNA (solid tissues), b103.6 per ml of blood and
b103.4 per ml of urine or viral transport medium (swabs).Virus isolation and titration
Isolation of infectious virus was routinely attempted from
swab specimens, urine, blood (diluted 1:10 (v/v) in phosphate
buffered saline) and solid tissues (as 10% (w/v) homogenates in
viral transport medium, prepared using a Mini-BeadBeater-
8 (Biospec Products, AB, Canada)) by inoculation of samples,
in duplicate, onto 80–90% confluent ovine testis cell mono-
layers (OA3.Ts; ATCC CRL-6546, Manassas, VA, USA) (Ba-
biuk et al., 2007) grown in 12-well plates (ICN Biomedicals
Canada Ltd., Mississauga, ON, Canada). Development of viral-
induced cytopathic effect on OA3.Ts cells was monitored for a
period of 10 to 14 days. Capripoxvirus-positive specimens were
subsequently titrated on replicate OA3.Ts cell monolayers
(Babiuk et al., 2007), and viral titers (TCID50/ml or TCID50/g)
were estimated using the method of Reed and Muench (1938).
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